Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-01

Clinical Trial Update: Testing Methylphenidate for Smoking Abstinence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether methylphenidate supports smoking abstinence; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: Mayo Clinic | Conditions: Smoking | Phase 2 | Status: COMPLETED | Results posted: 2010-11-01